oral vs injectable bpc 157 bpc-157 effectiveness comparison vs. a very different kind of peptide experiment 🧬 Quantity:10 ml Brand_Frog Neurobion injection-Composition,Uses, Dose,Contraindications -

oral vs injectable bpc 157 bpc-157 effectiveness comparison vs. a very different kind of peptide experiment 🧬 Quantity:10 ml Brand_Frog Neurobion injection-Composition,Uses, Dose,Contraindications -

Neurobion injection-Composition,Uses, Dose,Contraindications - YouTube

THIRD-PARTY TESTED, COA AVAILABLE: Made by Neurogan in a GMP-certified San Diego facility and third-party lab tested for purity

Brand_Frog

Quantity:10 ml

At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC₅₀ of 1.2 ± 0.1 μM under standard assay conditions (50 μM SAM, 100 μM nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" – a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity